NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Bryn Mawr Bank Corporation BMTC, Utah Medical Products, Inc. UTMD, Opiant Pharmaceuticals, Inc. OPNT, Whiting Petroleum Corporation WLL, International Business Machines Corporation IBM, and QUALCOMM Incorporated QCOM, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
BMTC DOWNLOAD: http://Fundamental-Markets.com/register/?so=BMTC
UTMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=UTMD
OPNT DOWNLOAD: http://Fundamental-Markets.com/register/?so=OPNT
WLL DOWNLOAD: http://Fundamental-Markets.com/register/?so=WLL
IBM DOWNLOAD: http://Fundamental-Markets.com/register/?so=IBM
QCOM DOWNLOAD: http://Fundamental-Markets.com/register/?so=QCOM
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Bryn Mawr Bank Corporation BMTC, Utah Medical Products, Inc. UTMD, Opiant Pharmaceuticals, Inc. OPNT, Whiting Petroleum Corporation WLL, International Business Machines Corporation IBM, and QUALCOMM Incorporated QCOM on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 30th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
BRYN MAWR BANK CORPORATION (BMTC) REPORT OVERVIEW
Bryn Mawr Bank's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Bryn Mawr Bank reported interest income of $33.20MM vs $29.51MM (up 12.48%) and basic earnings per share $0.63 vs $0.56 (up 12.50%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Bryn Mawr Bank reported interest income of $116.99MM vs $108.54MM (up 7.78%) and basic earnings per share $2.14 vs $0.96 (up 122.92%). Bryn Mawr Bank is expected to report earnings on April 19th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.55. The estimated EPS forecast for the next fiscal year is $3.34 and is expected to report on February 4th, 2019.
To read the full Bryn Mawr Bank Corporation (BMTC) report, download it here: http://Fundamental-Markets.com/register/?so=BMTC
-----------------------------------------
UTAH MEDICAL PRODUCTS, INC. (UTMD) REPORT OVERVIEW
Utah Medical Products' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Utah Medical Products reported revenue of $10.13MM vs $9.66MM (up 4.87%) and basic earnings per share $0.97 vs $0.78 (up 24.36%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Utah Medical Products reported revenue of $39.30MM vs $40.16MM (down 2.14%) and basic earnings per share $3.23 vs $3.16 (up 2.22%). Utah Medical Products is expected to report earnings on April 24th, 2018. The report will be for the fiscal period ending March 31st, 2018.
To read the full Utah Medical Products, Inc. (UTMD) report, download it here: http://Fundamental-Markets.com/register/?so=UTMD
-----------------------------------------
OPIANT PHARMACEUTICALS, INC. (OPNT) REPORT OVERVIEW
Opiant Pharmaceuticals' Recent Financial Performance
For the three months ended October 31st, 2017 vs October 31st, 2016, Opiant Pharmaceuticals reported revenue of $0.02MM vs $1.12MM (down 98.04%) and basic earnings per share -$2.77 vs -$0.30. For the twelve months ended July 31st, 2017 vs July 31st, 2016, Opiant Pharmaceuticals reported revenue of $18.45MM vs $9.90MM (up 86.37%) and basic earnings per share $3.27 vs -$4.09. Opiant Pharmaceuticals is expected to report earnings on March 15th, 2018. The report will be for the fiscal period ending January 31st, 2018. The reported EPS for the same quarter last year was $4.91. The estimated EPS forecast for the next fiscal year is -$1.00 and is expected to report on October 12th, 2018.
To read the full Opiant Pharmaceuticals, Inc. (OPNT) report, download it here: http://Fundamental-Markets.com/register/?so=OPNT
-----------------------------------------
WHITING PETROLEUM CORPORATION (WLL) REPORT OVERVIEW
Whiting Petroleum's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Whiting Petroleum reported revenue of $324.19MM vs $315.55MM (up 2.74%) and basic earnings per share -$3.16 vs -$9.88. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Whiting Petroleum reported revenue of $1,116.28MM vs $2,050.80MM (down 45.57%) and basic earnings per share -$21.28 vs -$45.40. Whiting Petroleum is expected to report earnings on February 21st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$1.12. The estimated EPS forecast for the next fiscal year is -$0.85 and is expected to report on February 21st, 2018.
To read the full Whiting Petroleum Corporation (WLL) report, download it here: http://Fundamental-Markets.com/register/?so=WLL
-----------------------------------------
INTERNATIONAL BUSINESS MACHINES CORPORATION (IBM) REPORT OVERVIEW
International Business Machines' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, International Business Machines reported revenue of $19,153.00MM vs $19,226.00MM (down 0.38%) and basic earnings per share $2.93 vs $2.99 (down 2.01%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, International Business Machines reported revenue of $79,919.00MM vs $81,741.00MM (down 2.23%) and basic earnings per share $12.43 vs $13.48 (down 7.79%). International Business Machines is expected to report earnings on April 17th, 2018. The report will be for the fiscal period ending March 31st, 2018. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $5.17. The reported EPS for the same quarter last year was $2.38. The estimated EPS forecast for the next fiscal year is $14.12 and is expected to report on January 17th, 2019.
To read the full International Business Machines Corporation (IBM) report, download it here: http://Fundamental-Markets.com/register/?so=IBM
-----------------------------------------
QUALCOMM INCORPORATED (QCOM) REPORT OVERVIEW
QUALCOMM's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, QUALCOMM reported revenue of $5,905.00MM vs $6,184.00MM (down 4.51%) and basic earnings per share $0.11 vs $1.08 (down 89.81%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, QUALCOMM reported revenue of $22,291.00MM vs $23,554.00MM (down 5.36%) and basic earnings per share $1.67 vs $3.84 (down 56.51%). QUALCOMM is expected to report earnings on January 31st, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.06. The estimated EPS forecast for the next fiscal year is $3.18 and is expected to report on November 7th, 2018.
To read the full QUALCOMM Incorporated (QCOM) report, download it here: http://Fundamental-Markets.com/register/?so=QCOM
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
